简体中文 | 繁體中文 | English

Funding News

2024-03-28 19:11 Lifezone Metals Closes Private Placement of US$50 Million of Unsecured Convertible Debentures
2024-03-22 21:09 Lifezone Metals Signs Binding Subscription Agreement for US$50 Million of Unsecured Convertible Debentures with Consortium of Marquee Mining Investors
2024-03-20 12:57 Moove secures USD $100 million Series B round
2024-03-14 14:00 Wind Point Partners Closes Fund X at $2.3 Billion Hard Cap
2024-03-13 15:52 Bear Robotics Lands $60 Million in Series C Funding from Tech Giant LG Electronics
2024-03-08 14:35 C₂N Diagnostics, LLC Announces Investment From Eisai Inc.
2024-03-01 11:38 Kenai Therapeutics Announces $82 Million Series A Financing to Advance Next Generation Allogeneic Cell Therapies for Neurological Diseases
2024-02-23 11:27 Rimkus Celebrates 40-year Legacy, Secures Investment from HGGC
2024-02-22 09:45 MMI Raises $110 Million in Series C Financing
2024-02-19 10:19 Overworld Raises $10M in Seed Funding to Develop Vibrant, Cross-Platform Online ARPG
2024-02-18 15:10 Cambridge Mechatronics Secures Over $40m Investment to Further Develop its Revolutionary Smartphone Imaging Technology
2024-02-08 10:34 Myrobalan Therapeutics Receives a Grant from the ALS Association to Advance its CSF1R Inhibitor Program
2024-01-30 13:53 Boston Metal Secures $20M in Series C2 Funding, Bringing Total Round to $282M
2024-01-24 15:13 EDX Markets Launches Clearinghouse for Crypto Trading and Announces Completion of Series B Funding Round
2024-01-19 13:16 Kiln Raises $17 Million in Funding to Power Global Expansion of Its Innovative Institutional Staking Platform
2024-01-18 12:42 Timeline, a Swiss Longevity Biotech, Secures Pivotal Financing Round with Support from Strategic Global Industry Leaders, including L’Oréal and Nestlé
2024-01-11 09:58 Lifezone Metals Announces Completion of Funding for Phase 1 Platinum, Palladium and Rhodium Recycling Joint Venture with Glencore
2024-01-11 09:03 Myrobalan Therapeutics Completes Series A Financing of $24 Million to Develop Potentially First-in-Class CNS Therapeutics with Restorative Potential
2024-01-09 09:57 Morgan Stanley Expansion Capital Leads $34M Series C Investment in Vortexa
2024-01-09 09:51 ENYO Pharma Announces a €39 Million Series C Financing and FDA Clearance to Advance Vonafexor in a Phase 2 Clinical Trial for Patients With Alport Syndrome